终末期肝病模型与血清钠比值在肝硬化患者预后判断中的价值

陈丽红; 胡乃中; 王亚雷

终末期肝病模型与血清钠比值在肝硬化患者预后判断中的价值

安徽医科大学第一附属医院消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3533
- HTML全文浏览量: 158
- PDF下载量: 721
- 被引次数: 0
出版历程
- 出版日期: 2011-10-20

The value of MESO (MELD/Na index) scoring system in predicting prognosis of patients with cirrhosis

摘要

摘要: 目的研究终末期肝病模型（MELD）与血清钠比值（MESO）预测失代偿期肝硬化患者短期预后的临床价值;比较MESO与MELD及Child-Turcotte-Pugh（CTP）评分系统的预后预测能力;MESO结合CTP在失代偿期肝硬化患者预后预测中的价值。方法选择2007年9月至2009年9月间入住本院消化科及感染科的179例符合入组标准的住院病例,根据设计的肝硬化患者MESO调查登记表登记相关临床资料。分别计算每例患者入院后的首次CTP、MELD及MESO的分值,应用受试者特征曲线（ROC）及曲线下面积（AUC）衡量各评分系统预测患者预后的能力,及CTP在同一等级内,MESO指数与患者预后的关系。结果以入院时间为起点,死亡或者研究终止时间为终点。3个月死亡组（3个月内死亡）的MESO指数及MELD分值明显高于3个月生存组（P<0.05）;MESO对3个月预后的预测能力优于MELD和CTP,Youden指数分别为60.92%、37.31%、30.12%;AUC分别为0.88、0.86、0.78（P<0.05）。CTP等级相同时,MESO指数>1.6组死亡率明显高于MESO...
- 肝硬化 /
- 终末期肝病模型 /
- 血清钠比值
Abstract: Objective To evaluate the value of MESO scoring system in predicting the prognosis of patients with decompensated cirrhosis and to compare the predictable value of MESO, MELD and CTP and to investigate the prognostic value of the combination of MESO and CTP in decompensated cirrhosis.Methods Here we present a retrospective cohort study of 179 decompensated cirrhotic hospitalized patients in gastrointestinal department or infectious department from september 2007 to september 2009.CTP, MELD, MESO score of each patient was calculated by using the information collected at the time of admission to our hospital respectively and the capacity of three scoring systems was evaluated for predicting the prognosis of cirrhotic patients according to the receiver characteristic curve and the area under the curve.Meanwhile, the relationship between the outcome of patients and MESO index within a single CTP class was investigated.Results 37 (20.67%) patients died within the first 3 months, MESO and MELD of 3-month death group are significantly higher than that of 3-month survival group (P<0.05) .MESO for predicting the 3-month prognosis is more efficient than MELD and CTP.Youden index is 60.92%, 37.31% and 30.12% respectively and AUC is 0.88, 0.86, 0.78 (P<0.05) respectively.Mortality in the group of MESO index more than 1.6 is higher than that in the group of MESO index less than 1.6 (P<0.05) within a single CTP class.Conclusion MESO is a useful predictor for short-and mediate-term prognosis in decompensated cirrhotic patients and it is better than MELD and CTP.Combination of MESO and CTP scoring system can predict the outcome of patients with cirrhosis more efficiently within a single class.
- liver cirrhosis /
- MELD /
- MESO

HTML全文

参考文献(10)

[1] Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intra-hepatic portosystemic shunts[J]. Hepatology, 2000, 31 (4) : 864-871.

[2]Wiesner R, Edwards E, Freeman R, et al.The United net-work for organ sharing liver disease severity score commit-tee:Model for end-stage liver disease (MELD) and alloca-tion of donor livers[J].Gastroenterology, 2003, 124 (1) :91-96.

[3] Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting[J]. Am J Gastroenterol, 2003, 98 (5) : 1167-1174.

[4]Huo TI, WANG YW, Yang YY, et al.Model for end-stageliver disease score to serum sodium ratio index as a prognos-tic predictor and its correlation with portal pressure in patientswith liver cirrhosis[J].Liver Int, 2007, 27 (4) :498-506.

[5] Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation[J]. Liver Transpl, 2001, 7 (7) : 567-580.

[6]http://depts.washington.edu/uwhep/calculations/meld-score.htm.

[7] Huo TI, Lin HC, Huo SC, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis[J]. Liver Transpl, 2008, 14 (6) : 837-844.

[8]Huo TI, Lin HC, Hsia CY, et al.The MELD-Na is an inde-pendent short-and long-term prognostic predictor for hep-atocellular carcinoma:a prospective survey[J].Dig LiverDis, 2008, 40 (11) :882-889.

[9] Biggins SW, Kim WR, Terrauh NA, et al. Evidence-based of serum sodium concentration incorporation into MELD[J]. Gastroenterology, 2006, 130 (6) : 1652-1660.

[10]Ruf AE, Kremers WK, Chavez LL, et al.Addition of serum so-dium into the MELD score predicts waiting list mortality betterthan MELD along[J].Liver Transpl, 2005, 11 (3) :336-343.

施引文献

资源附件(0)

访问统计